Clinical trial
Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon…
NCT00433069 · University Hospital, Geneva, Other · Completed
Key facts
| NCT number | NCT00433069 |
|---|---|
| Title | Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone |
| Official title | A Pilot Study of Treatment With Pegylated Interferon-Alpha2a, Ribavirin and Insulin Sensitizer Pioglitazone of Insulin Resistance (With the Exception of Diabetes) in Hepatitis C Virus Infection (The INSPIRED HCV Study) |
| Lead sponsor | University Hospital, Geneva, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Pioglitazone, Interferon Alfa-2a, Ribavirin |
| Enrollment | 5 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Feb 9, 2007 |
| Last update posted | May 28, 2015 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: